The manufacturer of a breast cancer drug which has been deemed "too expensive" to be offered by the NHS has hit back at the decision.
Dr Jayson Dallas, general manager of Roche Products Limited, declared it "an incredible injustice."
Despite Roche offering a significant discount, we are once again disappointed that Nice has not shown any flexibility on access to Kadcyla.
Refusing patients access to this drug is an incredible injustice and tantamount to turning the clock back in cancer research and development. We plan to appeal this decision.
More top news
Pretenders singer Chrissie Hynde has been criticised for comments she has made about rape victims.
The Clipper Round The World Yacht Race is due to begin in London today from St Katherine's Dock.
Once a year W11 comes alive with the colour of carnival. Everything you need to know about getting around and what to see in Notting Hill.